Integral Diagnostics Ltd. (AU:IDX)
ASX:IDX
Australian Market
Holding AU:IDX?
Track your performance easily

Integral Diagnostics Ltd. (IDX) Financial Statements

15 Followers

Integral Diagnostics Ltd. Financial Overview

Integral Diagnostics Ltd.'s market cap is currently ―. The company's EPS TTM is AU$-0.26; its P/E ratio is -11.49; and it has a dividend yield of 1.94%. Integral Diagnostics Ltd. is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is AU$0.05. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19
Income Statement-
Total Revenue----
Gross Profit----
EBIT----
EBITDA----
Net Income Common Stockholders----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 123.19MAU$ 62.20MAU$ 57.97MAU$ 20.97M
Total AssetsAU$ 783.01MAU$ 654.90MAU$ 580.47MAU$ 314.67M
Total DebtAU$ 340.99MAU$ 308.35MAU$ 277.85MAU$ 139.05M
Net DebtAU$ 217.80MAU$ 246.15MAU$ 219.88MAU$ 118.08M
Total LiabilitiesAU$ 435.77MAU$ 400.16MAU$ 352.13MAU$ 187.45M
Stockholders EquityAU$ 347.24MAU$ 254.74MAU$ 228.33MAU$ 127.22M
Cash Flow-
Free Cash Flow----
Operating Cash Flow----
Investing Cash Flow----
Financing Cash Flow----
Currency in AUD

Integral Diagnostics Ltd. Earnings and Revenue History

Integral Diagnostics Ltd. Debt to Assets

Integral Diagnostics Ltd. Cash Flow

Integral Diagnostics Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis